361 related articles for article (PubMed ID: 32593907)
1. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
3. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
4. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
6. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
8. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
[TBL] [Abstract][Full Text] [Related]
9. Overview of stimuli-responsive mesoporous organosilica nanocarriers for drug delivery.
Guimarães RS; Rodrigues CF; Moreira AF; Correia IJ
Pharmacol Res; 2020 May; 155():104742. PubMed ID: 32151682
[TBL] [Abstract][Full Text] [Related]
10. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
11. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
[TBL] [Abstract][Full Text] [Related]
12. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
Küçüktürkmen B; Rosenholm JM
Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
15. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
[TBL] [Abstract][Full Text] [Related]
18. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy.
Wang K; Lu J; Li J; Gao Y; Mao Y; Zhao Q; Wang S
J Control Release; 2021 Nov; 339():445-472. PubMed ID: 34637819
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for tissue-engineering applications.
Chen L; Zhou X; He C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
[TBL] [Abstract][Full Text] [Related]
20. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms.
Zhao H; Li Y; Chen J; Zhang J; Yang Q; Cui J; Shi A; Wu J
Colloids Surf B Biointerfaces; 2024 Feb; 234():113758. PubMed ID: 38241892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
